Cardiac Fibroblast-Derived 3D Extracellular Matrix Seeded with Mesenchymal Stem Cells as a Novel Device to Transfer Cells to the Ischemic Myocardium

Cardiovascular Engineering and Technology

Volumn 5, Issue 1, 2014, Pages 119-131

  Schmuck, Eric G ^a,c   Mulligan, Jacob D ^a   Ertel, Rebecca L ^a   Kouris, Nicholas A ^b   Ogle, Brenda M ^b   Raval, Amish N ^a,b   Saupe, Kurt W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Wisconsin Electric Machines and Power Electronics Consortium   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Cardiac; Cardiac fibroblast; Extracellular matrix; Heart failure; Myocardial infarction; Regeneration; Stem cell

Indexed keywords

CARDIOLOGY; CELL CULTURE; FIBROBLASTS; GLUES; GLUING; HEART; MASS SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; STEM CELLS; TRANSFER MATRIX METHOD;

CARDIAC; CARDIAC FIBROBLASTS; EXTRACELLULAR MATRICES; HEART FAILURE; MYOCARDIAL INFARCTION; REGENERATION;

SCAFFOLDS (BIOLOGY);

COLLAGEN; FIBRONECTIN; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; FLUORESCENCE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MALE; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE CHARACTERIZATION;

EID: 84894644058     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-013-0167-1     Document Type: Article

References (80)

1. Abdel-Latif, A., R. Bolli, I. M. Tleyjeh, V. M. Montori, E. C. Perin, C. A. Hornung, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167(10): 989-997, 2007. doi: 10. 1001/archinte. 167. 10. 989.
2. Bader, A., T. Schilling, O. E. Teebken, G. Brandes, T. Herden, G. Steinhoff, et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardiothorac. Surg. 14(3): 279-284, 1998.
3. Badylak, S. F., D. O. Freytes, and T. W. Gilbert. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 5(1): 1-13, 2009.
4. Badylak, S. F., J. E. Valentin, A. K. Ravindra, G. P. McCabe, and A. M. Stewart-Akers. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 14(11): 1835-1842, 2008. doi: 10. 1089/ten. tea; (2007. 0264).
5. Baharvand, H., M. Azarnia, K. Parivar, and S. K. Ashtiani. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J. Mol. Cell. Cardiol. 38(3): 495-503, 2005.
6. Berger, S., L. Dyugovskaya, A. Polyakov, and L. Lavie. Short-term fibronectin treatment induces endothelial-like and angiogenic properties in monocyte-derived immature dendritic cells: Involvement of intracellular VEGF and MAPK regulation. Eur. J. Cell Biol. 2012. doi: 10. 1016/j. ejcb. 2012. 02. 003.
7. Bolli, R., A. R. Chugh, D. D'Amario, J. H. Loughran, M. F. Stoddard, S. Ikram, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378(9806): 1847-1857, 2011. doi: 10. 1016/S0140-6736(11)61590-0.
8. Bonios, M., J. Terrovitis, C. Y. Chang, J. M. Engles, T. Higuchi, R. Lautamaki, et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. J. Nucl. Cardiol. 18(3): 443-450, 2011. doi: 10. 1007/s12350-011-9369-9.
9. Booth, C., S. A. Korossis, H. E. Wilcox, K. G. Watterson, J. N. Kearney, J. Fisher, et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J. Heart Valve Dis. 11(4): 457-462, 2002.
10. Bornstein, P. Matricellular proteins: an overview. J. Cell Commun. Signal. 3(3-4): 163-165, 2009. doi: 10. 1007/s12079-009-0069-z.
11. Borschel, G. H., R. G. Dennis, and W. M. Kuzon, Jr. Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast. Reconstr. Surg. 113(2): 595-602, 2004; (discussion 3-4).
12. Brizzi, M. F., G. Tarone, and P. Defilippi. Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche. Curr. Opin. Cell Biol. 24(5): 645-651, 2012. doi: 10. 1016/j. ceb. 2012. 07. 001.
13. Brown, B. N., R. Londono, S. Tottey, L. Zhang, K. A. Kukla, M. T. Wolf, et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater. 8(3): 978-987, 2012. doi: 10. 1016/j. actbio. 2011. 11. 031.
14. Bujak, M., and N. G. Frangogiannis. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74(2): 184-195, 2007. doi: 10. 1016/j. cardiores. 2006. 10. 002.
15. Chachques, J. C., J. C. Trainini, N. Lago, O. H. Masoli, J. L. Barisani, M. Cortes-Morichetti, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant. 16(9): 927-934, 2007.
16. Chang, H. Y., J. T. Chi, S. Dudoit, C. Bondre, M. van de Rijn, D. Botstein, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. U. S. A. 99(20): 12877-12882, 2002.
17. Chimenti, I., R. R. Smith, T. S. Li, G. Gerstenblith, E. Messina, A. Giacomello, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 106(5): 971-980, 2010.
18. Choi, H., and A. I. Nesvizhskii. False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J. Proteome Res. 7(1): 47-50, 2008. doi: 10. 1021/pr700747q.
19. Cortes-Morichetti, M., G. Frati, O. Schussler, J. P. Duong van Huyen, E. Lauret, J. A. Genovese, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 13(11): 2681-2687, 2007. doi: 10. 1089/ten; (2006. 0447).
20. Dubey, R. K., D. G. Gillespie, Z. Mi, and E. K. Jackson. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation 96(8): 2656-2666, 1997.
21. Dvir, T., A. Kedem, E. Ruvinov, O. Levy, I. Freeman, N. Landa, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. U. S. A. 106(35): 14990-14995, 2009. doi: 10. 1073/pnas. 0812242106.
22. Forest, V. F., A. M. Tirouvanziam, C. Perigaud, S. Fernandes, M. S. Fusellier, J. C. Desfontis, et al. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Res Ther. 1(1): 4, 2010.
23. Freytes, D. O., L. Santambrogio, and G. Vunjak-Novakovic. Optimizing dynamic interactions between a cardiac patch and inflammatory host cells. Cells Tissues Organs 195(1-2): 171-182, 2012. doi: 10. 1159/000331392.
24. Fries, K. M., T. Blieden, R. J. Looney, G. D. Sempowski, M. R. Silvera, R. A. Willis, et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin. Immunol. Immunopathol. 72(3): 283-292, 1994.
25. Gilbert, T. W., T. L. Sellaro, and S. F. Badylak. Decellularization of tissues and organs. Biomaterials 27(19): 3675-3683, 2006.
26. Giraud, M. N., E. Ayuni, S. Cook, M. Siepe, T. P. Carrel, and H. T. Tevaearai. Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif. Organs 32(9): 692-700, 2008. doi: 10. 1111/j. 1525-1594. 2008. 00595. x.
27. Giraud, M. N., R. Flueckiger, S. Cook, E. Ayuni, M. Siepe, T. Carrel, et al. Long-term evaluation of myoblast seeded patches implanted on infarcted rat hearts. Artif. Organs 34(6): E184-E192, 2010. doi: 10. 1111/j. 1525-1594. 2009. 00979. x.
28. Godier-Furnemont, A. F., T. P. Martens, M. S. Koeckert, L. Wan, J. Parks, K. Arai, et al. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl Acad. Sci. U. S. A. 108(19): 7974-7979, 2011. doi: 10. 1073/pnas. 1104619108.
29. Hamdi, H., V. Planat-Benard, A. Bel, E. Puymirat, R. Geha, L. Pidial, et al. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc. Res. 91(3): 483-491, 2011.
30. Hare, J. M., J. E. Fishman, G. Gerstenblith, D. L. Difede Velazquez, J. P. Zambrano, V. Y. Suncion, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON Randomized Trial. JAMA 1-11, 2012. doi: 10. 1001/jama. 2012. 25321.
31. Hare, J. M., J. H. Traverse, T. D. Henry, N. Dib, R. K. Strumpf, S. P. Schulman, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24): 2277-2286, 2009.
32. Hata, H., A. Bar, S. Dorfman, Z. Vukadinovic, Y. Sawa, A. Haverich, et al. Engineering a novel three-dimensional contractile myocardial patch with cell sheets and decellularised matrix. Eur. J. Cardiothorac. Surg. 38(4): 450-455, 2010. doi: 10. 1016/j. ejcts. 2010. 02. 009.
33. Hou, D., E. Youssef, T. Brinton, P. Zhang, P. Rogers, E. Price, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112(9 Suppl): I150-I156, 2005.
34. Hynes, R. O. The extracellular matrix: not just pretty fibrils. Science 326(5957): 1216-1219, 2009.
35. Janssens, S., C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, W. Desmet, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367(9505): 113-121, 2006.
36. Kalogeropoulos, A., V. Georgiopoulou, S. B. Kritchevsky, B. M. Psaty, N. L. Smith, A. B. Newman, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch. Intern. Med. 169(7): 708-715, 2009. doi: 10. 1001/archinternmed. 2009. 40.
37. Kawamura, M., S. Miyagawa, K. Miki, A. Saito, S. Fukushima, T. Higuchi, et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126(11 Suppl 1): S29-S37, 2012. doi: 10. 1161/CIRCULATIONAHA. 111. 084343.
38. Kellar, R. S., B. R. Shepherd, D. F. Larson, G. K. Naughton, and S. K. Williams. Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue Eng. 11(11-12): 1678-1687, 2005.
39. Konstandin, M. H., H. Toko, G. M. Gastelum, P. J. Quijada, A. De La Torre, M. Quintana, et al. Fibronectin is essential for reparative cardiac progenitor cell response following myocardial infarction. Circ. Res. 2013. doi: 10. 1161/CIRCRESAHA. 113. 301152.
40. Korossis, S. A., C. Booth, H. E. Wilcox, K. G. Watterson, J. N. Kearney, J. Fisher, et al. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J. Heart Valve Dis. 11(4): 463-471, 2002.
41. Kouris, N. A., J. A. Schaefer, M. Hatta, B. T. Freeman, T. J. Kamp, Y. Kawaoka, et al. Directed fusion of mesenchymal stem cells with cardiomyocytes via VSV-G facilitates stem cell programming. Stem Cells Int. 2012: 414038, 2012. doi: 10. 1155/2012/414038.
42. Kumar, D., T. A. Hacker, J. Buck, L. F. Whitesell, E. H. Kaji, P. S. Douglas, et al. Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron. Artery Dis. 16(1): 41-44, 2005.
43. Kuwabara, I., and F. T. Liu. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol. 156(10): 3939-3944, 1996.
44. Lekic, P. C., N. Pender, and C. A. McCulloch. Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit. Rev. Oral Biol. Med. 8(3): 253-268, 1997.
45. Makkar, R. R., R. R. Smith, K. Cheng, K. Malliaras, L. E. Thomson, D. Berman, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379(9819): 895-904, 2012. doi: 10. 1016/S0140-6736(12)60195-0.
46. Masuda, S., T. Shimizu, M. Yamato, and T. Okano. Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 60(2): 277-285, 2008.
47. Matsuura, K., Y. Haraguchi, T. Shimizu, and T. Okano. Cell sheet transplantation for heart tissue repair. J. Control. Rel. 169(3): 336-340, 2013. doi: 10. 1016/j. jconrel. 2013. 03. 003.
48. McCurdy, S. M., Q. Dai, J. Zhang, R. Zamilpa, T. A. Ramirez, T. Dayah, et al. SPARC mediates early extracellular matrix remodeling following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 301(2): H497-H505, 2011. doi: 10. 1152/ajpheart. 0; (1070. 2010).
49. Menasche, P., O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117(9): 1189-1200, 2008. doi: 10. 1161/CIRCULATIONAHA. 107. 734103.
50. Meyer, G. P., K. C. Wollert, J. Lotz, J. Pirr, U. Rager, P. Lippolt, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur. Heart J. 30(24): 2978-2984, 2009. doi: 10. 1093/eurheartj/ehp374.
51. Meyer, G. P., K. C. Wollert, J. Lotz, J. Steffens, P. Lippolt, S. Fichtner, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113(10): 1287-1294, 2006.
52. Mirotsou, M., Z. Zhang, A. Deb, L. Zhang, M. Gnecchi, N. Noiseux, et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl Acad. Sci. U. S. A. 104(5): 1643-1648, 2007. doi: 10. 1073/pnas. 0610024104.
53. Miyagawa, S., A. Saito, T. Sakaguchi, Y. Yoshikawa, T. Yamauchi, Y. Imanishi, et al. Impaired myocardium regeneration with skeletal cell sheets-a preclinical trial for tissue-engineered regeneration therapy. Transplantation 90(4): 364-372, 2010. doi: 10. 1097/TP. 0b013e3181e6f201.
54. Muller-Ehmsen, J., P. Whittaker, R. A. Kloner, J. S. Dow, T. Sakoda, T. I. Long, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34(2): 107-116, 2002.
55. Murry, C. E., M. H. Soonpaa, H. Reinecke, H. Nakajima, H. O. Nakajima, M. Rubart, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983): 664-668, 2004.
56. Pankov, R., and K. M. Yamada. Fibronectin at a glance. J. Cell Sci. 115(Pt 20): 3861-3863, 2002.
57. Pflieger, D., S. Chabane, O. Gaillard, B. A. Bernard, P. Ducoroy, J. Rossier, et al. Comparative proteomic analysis of extracellular matrix proteins secreted by two types of skin fibroblasts. Proteomics 6(21): 5868-5879, 2006.
58. Plow, E. F., T. A. Haas, L. Zhang, J. Loftus, and J. W. Smith. Ligand binding to integrins. J. Biol. Chem. 275(29): 21785-21788, 2000. doi: 10. 1074/jbc. R000003200.
59. Qian, H., Y. Yang, J. Huang, R. Gao, K. Dou, G. Yang, et al. Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts. J. Cell. Biochem. 102(1): 64-74, 2007.
60. Rabinovich, G. A., C. E. Sotomayor, C. M. Riera, I. Bianco, and S. G. Correa. Evidence of a role for galectin-1 in acute inflammation. Eur. J. Immunol. 30(5): 1331-1339, 2000. doi: 10. 1002/(SICI)1521-4141(200005)30: 5<1331:: AID-IMMU1331>3. 0. CO;2-H.
61. Rane, A. A., and K. L. Christman. Biomaterials for the treatment of myocardial infarction: a 5-year update. J. Am. Coll. Cardiol. 58(25): 2615-2629, 2011. doi: 10. 1016/j. jacc. 2011. 11. 001.
62. Ratner, B. D., and S. J. Bryant. Biomaterials: where we have been and where we are going. Annu. Rev. Biomed. Eng. 6: 41-75, 2004.
63. Rifkin, D. B. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J. Biol. Chem. 280(9): 7409-7412, 2005. doi: 10. 1074/jbc. R400029200.
64. Roger, V. L., A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, W. B. Borden, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125(1): e2-e220, 2012. doi: 10. 1161/CIR. 0b013e31823ac046.
65. Ruoslahti, E. Fibronectin and its receptors. Annu. Rev. Biochem. 57: 375-413, 1988. doi: 10. 1146/annurev. bi. 57. 070188. 002111.
66. Sano, H., D. K. Hsu, L. Yu, J. R. Apgar, I. Kuwabara, T. Yamanaka, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165(4): 2156-2164, 2000.
67. Schachinger, V., S. Erbs, A. Elsasser, W. Haberbosch, R. Hambrecht, H. Holschermann, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355(12): 1210-1221, 2006.
68. Schaefer, A., C. Zwadlo, M. Fuchs, G. P. Meyer, P. Lippolt, K. C. Wollert, et al. Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial-an echocardiographic study. Eur. J. Echocardiogr. 11(2): 165-171, 2010. doi: 10. 1093/ejechocard/jep191.
69. Silva, E. A., and D. J. Mooney. Synthetic extracellular matrices for tissue engineering and regeneration. Curr. Top. Dev. Biol. 64: 181-205, 2004.
70. Singla, D. K., T. A. Hacker, L. Ma, P. S. Douglas, R. Sullivan, G. E. Lyons, et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J. Mol. Cell. Cardiol. 40(1): 195-200, 2006.
71. Tan, M. Y., W. Zhi, R. Q. Wei, Y. C. Huang, K. P. Zhou, B. Tan, et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30(19): 3234-3240, 2009. doi: 10. 1016/j. biomaterials. 2009. 02. 013.
72. Terrovitis, J., R. Lautamaki, M. Bonios, J. Fox, J. M. Engles, J. Yu, et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J. Am. Coll. Cardiol. 54(17): 1619-1626, 2009. doi: 10. 1016/j. jacc. 2009. 04. 097.
73. Terrovitis, J. V., R. R. Smith, and E. Marban. Assessment and optimization of cell engraftment after transplantation into the heart. Circ. Res. 106(3): 479-494, 2010. doi: 10. 1161/CIRCRESAHA. 109. 208991.
74. Trivedi, P., and P. Hematti. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp. Hematol. 36(3): 350-359, 2008. doi: 10. 1016/j. exphem. 2007. 10. 007.
75. Valentin, J. E., A. M. Stewart-Akers, T. W. Gilbert, and S. F. Badylak. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng. Part A 15(7): 1687-1694, 2009. doi: 10. 1089/ten. tea; (2008. 0419).
76. Vunjak-Novakovic, G., N. Tandon, A. Godier, R. Maidhof, A. Marsano, T. P. Martens, et al. Challenges in cardiac tissue engineering. Tissue Eng. B 16(2): 169-187, 2010. doi: 10. 1089/ten. TEB; (2009. 0352).
77. Wei, H. J., C. H. Chen, W. Y. Lee, I. Chiu, S. M. Hwang, W. W. Lin, et al. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials 29(26): 3547-3556, 2008. doi: 10. 1016/j. biomaterials. 2008. 05. 009.
78. Westermann, D., J. Mersmann, A. Melchior, T. Freudenberger, C. Petrik, L. Schaefer, et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117(10): 1269-1276, 2008. doi: 10. 1161/CIRCULATIONAHA. 107. 714147.
79. Willems, I. E., J. W. Arends, and M. J. Daemen. Tenascin and fibronectin expression in healing human myocardial scars. J. Pathol. 179(3): 321-325, 1996. doi: 10. 1002/(SICI)1096-9896(199607)179: 3<321:: AID-PATH555>3. 0. CO;2-8.
80. Zimmermann, W. H., I. Melnychenko, G. Wasmeier, M. Didie, H. Naito, U. Nixdorff, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4): 452-458, 2006.